Immuneering Corp. (IMRX)
4.07
+0.04
(+0.99%)
USD |
NASDAQ |
Oct 02, 16:00
4.07
0.00 (0.00%)
After-Hours: 20:00
Immuneering Price to Book Value : 1.380 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.380 |
| October 01, 2026 | 1.367 |
| September 30, 2026 | 1.389 |
| September 29, 2026 | 1.401 |
| September 28, 2026 | 1.411 |
| September 25, 2026 | 1.448 |
| September 24, 2026 | 1.472 |
| September 23, 2026 | 1.486 |
| September 22, 2026 | 1.564 |
| September 21, 2026 | 1.506 |
| September 18, 2026 | 1.520 |
| September 17, 2026 | 1.513 |
| September 16, 2026 | 1.509 |
| September 15, 2026 | 1.506 |
| September 14, 2026 | 1.469 |
| September 11, 2026 | 1.448 |
| September 10, 2026 | 1.550 |
| September 09, 2026 | 1.564 |
| September 08, 2026 | 1.621 |
| September 04, 2026 | 1.635 |
| September 03, 2026 | 1.710 |
| September 02, 2026 | 1.703 |
| September 01, 2026 | 1.645 |
| August 31, 2026 | 1.693 |
| August 28, 2026 | 1.693 |
| Date | Value |
|---|---|
| August 27, 2026 | 1.767 |
| August 26, 2026 | 1.747 |
| August 25, 2026 | 1.774 |
| August 24, 2026 | 1.757 |
| August 21, 2026 | 1.798 |
| August 20, 2026 | 1.781 |
| August 19, 2026 | 1.808 |
| August 18, 2026 | 1.706 |
| August 17, 2026 | 1.771 |
| August 14, 2026 | 1.716 |
| August 13, 2026 | 1.764 |
| August 12, 2026 | 1.720 |
| August 11, 2026 | 1.628 |
| August 10, 2026 | 1.537 |
| August 07, 2026 | 1.530 |
| August 06, 2026 | 1.513 |
| August 05, 2026 | 1.489 |
| August 04, 2026 | 1.492 |
| August 03, 2026 | 1.414 |
| July 31, 2026 | 1.401 |
| July 30, 2026 | 1.435 |
| July 29, 2026 | 1.376 |
| July 28, 2026 | 1.438 |
| July 27, 2026 | 1.479 |
| July 24, 2026 | 1.465 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.628 |
| Alnylam Pharmaceuticals, Inc. | 21.70 |
| Savara, Inc. | 6.877 |
| Vericel Corp. | 5.552 |
| Biogen, Inc. | 1.723 |
Price to Book Value Related Metrics
| Price | 4.07 |
| Earnings Yield | -25.35% |
| Market Cap | 263.32M |